The chairman of Switzerland-based Roche Group says the $300 million investment into the expansion of the Roche Diagnostics Corp. campus in Indianapolis is a "clear expression" of the company’s confidence and commitment in its facilities and employees. Christoph Franz says he believes the company will continue to grow and offer more jobs in the future. Roche Diagnostics recently celebrated the completion of the first phase of the expansion project.
Franz says Roche wants to continue to be part of the Indianapolis community, an idea that is demonstrated by the campus’ open feel. He says the investment into upgrades at the campus is a statement that the company cares about it employees.
"Our employer reputation is something which is the basis for our success in the future," said Franz. "Roche needs innovation and this innovation is provided by the brightest minds, so we have to be able to attract the best talents of the country to come to this state, come to this place on this campus in order to help us develop these fantastic instruments."
He says the fact that the company is able to attract top talent is one of the big pluses of the city.
"It’s a place where cost of living is reasonable. It’s a place which is great for families," said Franz. "There are a lot of elements which very positive and that’s also the reason why we are very much committed to Indianapolis."
The first phase of the expansion included new and refurbished buildings, improved infrastructure and investments in diabetes care manufacturing technology. The project was announced in 2012, when the company said it would make continued investments over 10 years.